Page 176 - Remedial Andrology

163. Holmegard, H.N., et al. Endogenous sex hormones and risk of venous thromboembolism in women
and men. J Thromb Haemost, 2014. 12: 297.
https://pubmed.ncbi.nlm.nih.gov/24329981
164. Glueck, C.J., et al. Testosterone therapy, thrombosis, thrombophilia, cardiovascular events.
Metabolism, 2014. 63: 989.
https://pubmed.ncbi.nlm.nih.gov/24930993
165. Smith, A.M., et al. Testosterone does not adversely affect fibrinogen or tissue plasminogen activator
(tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina. Eur
J Endocrinol, 2005. 152: 285.
https://pubmed.ncbi.nlm.nih.gov/15745938
166. Madaeva, I.M., et al. [Obstructive sleep apnea syndrome and age-related hypohonadism]. Zh Nevrol
Psikhiatr Im S S Korsakova, 2017. 117: 79.
https://pubmed.ncbi.nlm.nih.gov/28777369
167. Hoyos, C.M., et al. Body compositional and cardiometabolic effects of testosterone therapy in
obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. Eur
J Endocrinol, 2012. 167: 531.
https://pubmed.ncbi.nlm.nih.gov/22848006
168. Mottet, N., et al. Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone
Acetate Combined with Castration Is Another Standard. Eur Urol, 2017: S0302.
https://pubmed.ncbi.nlm.nih.gov/29103760
169. Eardley, I. The Incidence, Prevalence, and Natural History of Erectile Dysfunction. Sex Med Rev,
2013. 1: 3.
https://pubmed.ncbi.nlm.nih.gov/27784558
170. Feldman, H.A., et al. Impotence and its medical and psychosocial correlates: results of the
Massachusetts Male Aging Study. J Urol, 1994. 151: 54.
https://pubmed.ncbi.nlm.nih.gov/8254833
171. Braun, M., et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int
J Impot Res, 2000. 12: 305.
https://pubmed.ncbi.nlm.nih.gov/11416833
172. Johannes, C.B., et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal
results from the Massachusetts male aging study. J Urol, 2000. 163: 460.
https://pubmed.ncbi.nlm.nih.gov/10647654
173. Schouten, B.W., et al. Incidence rates of erectile dysfunction in the Dutch general population.
Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study. Int J Impot
Res, 2005. 17: 58.
https://pubmed.ncbi.nlm.nih.gov/15510192
174. Capogrosso, P., et al. One patient out of four with newly diagnosed erectile dysfunction is a young
man--worrisome picture from the everyday clinical practice. J Sex Med, 2013. 10: 1833.
https://pubmed.ncbi.nlm.nih.gov/23651423
175. Saitz, T.R., et al. The epidemiology of premature ejaculation. Transl Androl Urol, 2016. 5: 409.
https://pubmed.ncbi.nlm.nih.gov/27652213
176. Waldinger, M.D. The neurobiological approach to premature ejaculation. J Urol, 2002. 168: 2359.
https://pubmed.ncbi.nlm.nih.gov/12441918
177. Althof, S.E., et al. International Society for Sexual Medicine’s guidelines for the diagnosis and
treatment of premature ejaculation. J Sex Med, 2010. 7: 2947.
https://pubmed.ncbi.nlm.nih.gov/21050394
178. Hatzimouratidis, K., et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature
ejaculation. Eur Urol, 2010. 57: 804.
https://pubmed.ncbi.nlm.nih.gov/20189712
179. McMahon, C.G., et al. An evidence-based definition of lifelong premature ejaculation: report of the
International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature
ejaculation. J Sex Med, 2008. 5: 1590.
https://pubmed.ncbi.nlm.nih.gov/18466262
180. Carson, C., et al. Premature ejaculation: definition and prevalence. Int J Impot Res, 2006. 18 Suppl
1: S5.
https://pubmed.ncbi.nlm.nih.gov/16953247
181. Laumann, E.O., et al. Sexual dysfunction in the United States: prevalence and predictors. Jama,
1999. 281: 537.
https://pubmed.ncbi.nlm.nih.gov/10022110

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 175